Baseline characteristics of the thirty trials.
收藏数据链接：
官方服务：
资源简介：
NR: not reported.*unbalanced between groups.CT: chemotherapy; bev: bevacizumab; erl: erlotinib; cet: cetuximab; gef: gefitinib.GP: Cisplatin-Gemcitabine; PCp: Paclitaxel-carboplatin; TC: Taxane-carboplatin; NP: cisplatin-vinorelbine; D/M:docetaxel/pemetrexed.
创建时间：
2015-12-02
